DEFINITIVE PROXY STATEMENT

Company

RELMADA THERAPEUTICS, INC.

Filed

December 30, 2016

Period of Report

January 27, 2016

Accession Number

0001213900-16-019804

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →